Navigation Links
Deliver siRNAs Into Primary Cells

siPORT siRNA Electroporation Kit
Deliver siRNA into primary cells, cells grown in suspension, and other difficult-to-transfect cells

Maintain high cell viability under a wide range of conditions

Optimize electroporation of your cells quickly with included positive and negative controls


Primary cells serve as an important model system for gene function analysis, target validation, and drug discovery since they are more similar to their in vivo counterparts than are immortalized cells. However, delivery of siRNA into these cells has proven to be a challenge. Efficient transfer of siRNA into primary cells by chemical transfection (e.g. using lipid-based reagents) works with only a few cell types [1]. Ambion's new siPORT siRNA Electroporation Buffer overcomes this problem. It can be used with commonly available electroporators to ensure highly efficient siRNA delivery into many different cell types, including primary cells, while maintaining high levels of cell viability [2].

Now, Ambion introduces the siPORT siRNA Electroporation Kit, which provides a Cy3-labeled siRNA Control, and positive (GAPDH) and negative (non-targeting) siRNA controls in addition to the siPORT siRNA Electroporation Buffer. The kit makes it easy to optimize electroporation conditions for any cell type. For instance, successful delivery of siRNA into cells by electroporation depends on several critical parameters: voltage, pulse length, number of pulses, and siRNA concentration. The Cy3-labeled control siRNA makes it simple to monitor the uptake of siRNA into the target cells by fluorescence microscopy. The siPORT siRNA Electroporation Kit provides the means to dramatically simplify and speed up the electroporation optimization process, because a well-characterized siRNA targeting GAPDH and a widely used negative control siRNA and detailed optimization instructions are also included.


A Complete System for Optimization of siRNA Delivery

As seen in Figure 1, electroporation was used to deliver Cy3-labeled siRNA into human primary mesenchymal stem cells (hMSC) and rat neuronal pheochromocytoma (PC-12) cells. Almost every cell (>90%) contained detectable amounts of Cy3-labeled siRNA 24 hours after electroporation. This is a useful preliminary experiment to quickly screen multiple transfection conditions when working with new cell lines. A Cy3-labeled negative control siRNA comes with the kit for this purpose.

Figure 1. Electroporation of Primary Cells and Hard-to-transfect Neuronal Cells. A Cy3-labeled GAPDH siRNA (1.5 g) was added to primary Human Mesenchymal Stem Cells (hMSC) or rat neuronal pheochromocytoma (PC-12) cells in siPORT Electroporation Buffer (75 l) and electroporated using hMSC-specific or PC-12-specific parameters. Cells were fixed 24 hours after electroporation, stained with DAPI (blue), and analyzed by fluorescence microscopy (Cy3 fluorescence; red).


Because knockdown of gene expression in some cell types may not correlate 100% with uptake of fluorescently labeled siRNA, the siPORT siRNA Electroporation Kit also includes a positive control siRNA that targets GAPDH. The unlabeled GAPDH siRNA control can be used in conjunction with the unlabeled negative control siRNA (also included) to refine electroporation conditions by monitoring knockdown of GAPDH mRNA levels. The negative control siRNA is important not only for optimization experiments, but also for any siRNA experiment to confirm the absence of nonspecific effects due to transfection.

The siPORT siRNA Electroporation Kit has been tested with two commonly used single-cuvette electro-pulse generators: Gene Pulser Xcell (Bio-Rad) and ECM 830 (BTX). Their performance was similar when the same electroporation parameters were used.


Effective Silencing in Primary Cells

Figure 2 shows gene silencing induced by several different siRNAs, all delivered into hMSC and NHDF-neo cells (both are primary cells: human mesenchymal stem cells, and normal human dermal fibroblasts-neonatal) by electroporation using siPORT siRNA Electroporation Buffer. A critical parameter in the success of any RNAi experiment is the potency and specificity of siRNA sequences. To ensure the success of these gene-silencing experiments we used Silencer Pre-designed siRNAs. These siRNAs are designed using an extensively tested algorithm developed by Cenix BioScience, and have been shown to be highly effective at silencing target genes. As seen in Figure 2, 48 hours after transfection, mRNA expression levels of the targeted genes were reduced by 70% or more for all siRNAs tested in both cell types.

Figure 2. siRNAs Electroporated into hMSC and NHDF-neo Cells. Six siRNAs (1.5 g) targeting CDK2, JAK1, p53, GAPDH, uPAR, PKR, as well as a negative control siRNA, were electroporated into hMSC cells (A). Seven siRNAs (1.5 g) targeting Cyclin D1, NFκBp65, STAT1, PKCα, JAK1, RAF1, MMP-2, and a negative control siRNA were individually electroporated into NHDF-neo cells (B). All electroporations were conducted using the siPORT siRNA Electroporation Kit. 48 hours after electroporation, the cells were harvested and analyzed by real-time RT-PCR for corresponding gene expression levels. 18S rRNA levels were used to normalize the expression data. Percent remaining gene expression was calculated as a percentage of target mRNA compared with target mRNA from cells electroporated with the negative control siRNA.


Effective Gene Silencing in Primary and Difficult-to-Transfect Cells

In Figure 3, several different cell types were electroporated with the GAPDH control siRNA using individually optimized electroporation conditions. 48 hours after electroporation, GAPDH mRNA levels were reduced by 70% or more in each cell type. Cell viability of 70% or greater was maintained (Figure 3). Ambion scientists have optimized electroporation conditions for many different cell types. These electroporation conditions are available on our Electroporation Buffer webpage (see uppermost data table on right side of page).

Figure 3. Cell Viability and Reduction of GAPDH Gene Expression in Several Cell Types. Successful gene silencing and high cell viability was achieved in 11 primary cell types and 3 hard-to-transfect immortalized cell lines: Primary Cells: human mesenchymal stem cells (hMSC), normal human astrocyte cells (NHA), normal human dermal fibroblasts-neonatal (NHDF-Neo), rat astrocytes (DI TNC1), normal human umbilical vein endothelial cells (HUVEC), bovine aortic endothelial cells (BAEC), bovine aortic vascular smooth muscle cells (BAVSMC), bovine adrenal microvascular endothelial cells (BAMEC), mouse embryo fibroblast (MEF), rhesus monkey stem cells (RMSC), bovine lung microvascular endothelial cells (BLMVEC) are shown in blue. Hard-to-transfect cell lines: Jurkat (human acute T-cells), K562 (human erythroleukemia cells), PC12 (rat pheochromocytoma cells) are shown in black.

siRNA targeting GAPDH or a negative control siRNA (1.5 g) were electroporated. 48 hours after transfection, the cells were harvested and analyzed by real time RT-PCR for gene expression levels. 18S rRNA levels were used to normalize GAPDH expression. Remaining gene expression was calculated as a percentage of gene expression compared with the negative control siRNA.


Summary
Ambion's siPORT siRNA Electroporation Kit provides a streamlined protocol, with the necessary reagents for delivering siRNAs into multiple cell types. Because some biologically important cell types are refractory to other methods of transfection, electroporation can greatly simplify siRNA studies in these cell lines.


Scientific Contributors
Dmitriy Ovcharenko, Po-Tsan Ku, Kevin Kelnar, Nitin Puri Ambion, Inc.


back to top


Ordering Information
Cat# Product Name Size 1629 siPORT siRNA Electroporation Kit 60 rxns 8990 siPORT siRNA Electroporation Buffer 12 x 1.5 ml
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. pFB-ERV: Retroviral Delivery of the Ecdysone Receptor Proteins
2. High-Titer Retroviral Vectors for Gene Delivery
3. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
4. A New Way to Assess siRNA Delivery Efficiency
5. Delivering siRNA Using Adenoviral Vectors
6. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
7. Delivering siRNAs to Difficult Cell Types
8. Enhanced siRNA Delivery and Long-term Gene Silencing
9. High Throughput siRNA Delivery In Vitro: From Cell Lines to Primary Cells
10. Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice
11. Silencer Validated siRNAs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Deliver siRNAs Into Primary Cells

(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ) ... ) has submitted a pre-market approval application to the ... of Medtronic,s SynchroMed ® II implantable drug infusion ... United Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market ... (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, ... Forecasts to 2019” provides a detailed overview of ... trends, and strategies impacting the preparative and process ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... , , , , FLEXSTATION IS A ... SIMPLE, RAPID EXPERIMENTAL SET-UP AND DATA ANALYSIS , , ... , EXCELLENT FOR ASSAY DEVELOP-MENT AS DEMONSTRATED BY Z FACTOR ... G q -coupled receptors are transmembrane proteins that are responsible ...
... , , NO WASH STEPS , , ... HIGHER SIGNAL INTENSITY , , IMPROVED DATA QUALITY , ... FLIPR ASSAYS FOR GPCRS ... GPCR targets are preferred techniques in drug discovery because they generate high quality ...
... McGown, Ph.D. , Michael Su, M.S. and Jin Liao, M.D., Ph.D., ... Molecular Devices Corporation, 8/00 , , ... firefly (Photinus pyralis) is very popular foruse in Reporter Gene Assays. ... of light (Figure 1) 1 . When luciferase is the limiting ...
Cached Biology Technology:Gq-coupled receptor assays using FLEXstation: M1 muscarinic receptor 2Gq-coupled receptor assays using FLEXstation: M1 muscarinic receptor 3Gq-coupled receptor assays using FLEXstation: M1 muscarinic receptor 4FLIPR Calcium 3 Assay Kit Datasheet 2FLIPR Calcium 3 Assay Kit Datasheet 3Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38) 2Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38) 3Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38) 4
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
(Date:12/19/2014)... LaunchKey , the first decentralized mobile authentication and authorization ... era, today announced the close of $3 million in ... Metamorphic Ventures with participation from ENIAC Ventures, Crosslink Capital, ... has raised $4 million to date, and will use ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming in ... in biomedical applications. Chemical sensors help in recording of ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... human and animal research released today demonstrates how experiences ... presented at Neuroscience 2013, the annual meeting of the ... emerging news about brain science and health, provide new ... in behaviors like drug addiction and memory formation. ...
... Some vegetable oils that claim to be healthy may ... Canada should reconsider cholesterol-lowering claims on food labelling, states ... Medical Association Journal ) ., Replacing saturated animal fats ... they can reduce serum cholesterol levels and help prevent ...
... A condition of publishing in the Open Access life sciences ... the data underlying their findings publicly available alongside the article. ... issues around the lack of reproducibility of much published research, ... data plotting tool from F1000Research enables the data ...
Cached Biology News:Nurture impacts nature: Experiences leave genetic mark on brain, behavior 2Some 'healthy' vegetable oils may actually increase risk of heart disease 2F1000Research launch data plotting tool 2
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of Human MSY2/YBOX2. (Note: the ... (Peptide available as ...
Biology Products: